Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 312 (18), 1905-17

Treatment of Syphilis: A Systematic Review

Affiliations
Review

Treatment of Syphilis: A Systematic Review

Meredith E Clement et al. JAMA.

Abstract

Importance: The incidence of syphilis in the United States is increasing; it is estimated that more than 55,000 new infections will occur in 2014. Treatment regimens are controversial, especially in specific populations, and assessing treatment response based on serology remains a challenge.

Objective: To review evidence regarding penicillin and nonpenicillin regimens, implications of the "serofast state," and treatment of specific populations including those with neurosyphilis or human immunodeficiency virus (HIV) infection and pregnant women.

Evidence review: We searched MEDLINE for English-language human treatment studies dating from January 1965 until July 2014. The American Heart Association classification system was used to rate quality of evidence.

Findings: We included 102 articles in our review, consisting of randomized trials, meta-analyses, and cohort studies. Case reports and small series were excluded unless they were the only studies providing evidence for a specific treatment strategy. We included 11 randomized trials. Evidence regarding penicillin and nonpenicillin regimens was reviewed from studies involving 11,102 patients. Data on the treatment of early syphilis support the use of a single intramuscular injection of 2.4 million U of benzathine penicillin G, with studies reporting 90% to 100% treatment success rates. The value of multiple-dose treatment of early syphilis is uncertain, especially in HIV-infected individuals. Less evidence is available regarding therapy for late and late latent syphilis. Following treatment, nontreponemal serologic titers should decline in a stable pattern, but a significant proportion of patients may remain seropositive (the "serofast state"). Serologic response to treatment should be evident by 6 months in early syphilis but is generally slower (12-24 months) for latent syphilis. Evidence defining treatment for HIV-infected persons and for pregnant women is limited, but available data support penicillin as first-line therapy.

Conclusions and relevance: The mainstay of syphilis treatment is parenteral penicillin G despite the relatively modest clinical trial data that support its use.

Conflict of interest statement

Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Hicks reports contracted research agreements with Argos, Bristol-Myers Squibb, Gilead, Janssen, Merck, and ViiV and consulting fees from Bristol-Myers Squibb, Gilead, Janssen, Merck, and ViiV. No other disclosures were reported.

Figures

Figure.
Figure.. Suggested Algorithm for Treatment of Syphilis
BPG indicates benzathine penicillin G; CSF, cerebrospinal fluid; IM, intramuscular; IV, intravenous. a Some clinicians would treat patients with syphilis who have neurologic symptoms for neurosyphilis despite negative diagnostic CSF test results.

Comment in

Similar articles

See all similar articles

Cited by 30 PubMed Central articles

  • Syphilitic Hepatitis: Case Report of an Overlooked Condition
    P Marcos et al. Clin Case Rep 8 (1), 123-126. PMID 31998501. - Case Reports
    Syphilis is an overlooked cause of hepatitis. Syphilitic hepatitis should be a differential diagnosis in all patients with abnormal liver biochemical marker levels. Syphi …
  • Treatment Strategies for Neuroretinitis: Current Options and Emerging Therapies
    AM Fairbanks et al. Curr Treat Options Neurol 21 (8), 36. PMID 31278547. - Review
    The optimum treatment strategy for neuroretinitis due to Bartonella henselae in immunocompetent individuals is not clear and a matter of debate. The role of systemic cort …
  • Syphilis
    P O'Byrne et al. BMJ 365, l4159. PMID 31253629.
  • Cytokine Expression in Treponema Pallidum Infection
    N Kojima et al. J Transl Med 17 (1), 196. PMID 31186010.
    Differences in cytokine profiles are present among men and male-to-female transgender women with active and treated syphilis. Cytokine assays may be a potentially useful …
  • Antibiotic Therapy for Adults With Neurosyphilis
    D Buitrago-Garcia et al. Cochrane Database Syst Rev 5 (5), CD011399. PMID 31132142.
    Due to low quality and insufficient evidence, it was not possible to determine whether there was a difference between treatment with ceftriaxone or Penicillin G. Also, th …
See all "Cited by" articles

Substances

Feedback